Westlake Chemical Partners LP Stock Price and Value Analysis

Westlake Chemical Partners LP (NYSE:WLKP) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Westlake Chemical Partners LP to reach your target.

Target type

WLKP Free Cash Flow Trend

Free Cash Flow trendline for WLKP
Free Cash Flow trendline for Westlake Chemical Partners LP
CSV

Based on historical returns, we believe that Westlake Chemical Partners LP can grow its free cash at a rate of about 17%. That's positive!

AdvantagesDisadvantages
  • This company has fluctuating growth.
  • This company is making money at a great rate!
  • This company has a large dividend yield!
  • This company is less known than others.
  • This stock looks overpriced.

Inside the WLKP Numbers

WLKP Price
(Westlake Chemical Partners LP stock price per share)
$20.72
[?] WLKP Fair Price
(based on intrinsic value)
$14.75
[?] WLKP Safety Price (based on a variable margin of safety) $8.85
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 7% lower than other Basic Materials stocks
[?] PE Ratio versus Industry 0% lower than other Chemicals stocks
[?] Free Cash Flow Jitter 32%
[?] Dividend Yield 8.99% (tax impact)
Shares Shorted 148,107

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

Recent Insider Activity

Open-market buys and sells reported by Westlake Chemical Partners LP's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2025-08-27 Gilson Jean-Marc (President and CEO) Buy 95.29 $21.25
2025-08-21 Gilson Jean-Marc (President and CEO) Buy 1,250 $22.02
2025-08-20 Gilson Jean-Marc (President and CEO) Buy 1,250 $21.86
2025-08-15 Gilson Jean-Marc (President and CEO) Buy 4,700 $21.84
2025-05-29 Chao James (Senior Chairman) Sell 3,700 $22.10
2025-05-29 Gilson Jean-Marc (President and CEO) Buy 93.728 $22.20
2025-05-28 Chao James (Senior Chairman) Sell 4,600 $22.10
2025-05-27 Chao James (Senior Chairman) Sell 5,608 $22.17
2025-02-25 Gilson Jean-Marc (President and CEO) Buy 82.507 $24.75
2024-11-27 Gilson Jean-Marc (President and CEO) Buy 84.96 $23.57

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 148,107 shares shorted. With 19,436,250 shares available for purchase and an average trading volume over the past 10 trading days of 29,960, it would take at least 4.9 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2014 1604665 401
2015 1604665 236
2016 1604665 43.2
2017 1604665 337
2018 1604665 268
2019 1604665 314
2020 1604665 276
2021 1604665 354
2022 1604665 413
2023 1604665 399
2024 1604665 431
2025 1604665 218

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 12 fiscal years from 2014 to 2025 with positive net income, operating cash flow totaled $5,232 million against net income of $632 million, or 8.28 times.

In 2025, operating cash flow was 5.76 times net income, compared with 14.25 times for the earliest three years (2014 to 2016).

In 2025, capital expenditures were $78.8 million, 28.1% of operating cash flow of $280 million, which leaves an estimated $202 million after capex. Across the 12 years with reported capex, it averaged 23.6% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Cash conversion in 2025 was 5.76, at least 0.25 under the 14.25 earliest three-year ratio. Gaps like this come from non-cash gains or from cash tied up in receivables, inventory or other working capital.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2014 13.6 604 203 44.49
2015 39.8 453 231 11.36
2016 40.9 288 300 7.03
2017 48.7 537 68.9 11.04
2018 49.3 436 39.9 8.84
2019 61 451 43.7 7.39
2020 66.2 373 37 5.64
2021 82.5 408 81.2 4.95
2022 64.2 464 54.1 7.23
2023 54.3 452 46.8 8.33
2024 62.4 485 49 7.77
2025 48.7 280 78.8 5.76

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $1,750 million in 2014 and $1,167 million in 2025, a compound annual growth rate of -3.6% over 11 years.

Revenue rose 2.7% from 2024 to 2025.

Our estimated free cash flow was $218 million in 2025, 18.7% of revenue. In 2014 the estimated margin was 22.9%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2014 1,750 401 22.9%
2015 1,007 236 23.4%
2016 987 43.2 4.4%
2017 1,173 337 28.7%
2018 1,286 268 20.8%
2019 1,092 314 28.8%
2020 967 276 28.5%
2021 1,215 354 29.2%
2022 1,593 413 25.9%
2023 1,191 399 33.5%
2024 1,136 431 38.0%
2025 1,167 218 18.7%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $44.3 million against total liabilities of $454 million, or 9.7% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 36.1% of total assets in 2025, compared with 23.8% in 2014, an increase of 12.3 percentage points.

Stockholders equity was $802 million in 2025, compared with $835 million in 2014, a fall of 3.9%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 18.8% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2014 1,096 134 261 835
2015 1,290 170 443 847
2016 1,555 88.9 634 921
2017 1,515 27 517 999
2018 1,462 19.7 528 934
2019 1,393 19.9 441 952
2020 1,356 17.2 441 915
2021 1,481 17.1 508 973
2022 1,372 64.8 468 904
2023 1,317 58.6 461 856
2024 1,288 58.3 459 829
2025 1,257 44.3 454 802

Price Versus Our Estimated Value

Every one of the 12 fiscal years we have for Westlake Chemical Partners LP under its current filer shows positive free cash flow.

Comparing the first and last three years of data, average free cash flow rose sharply: $227 million at the start and $350 million most recently.

Free cash flow is uneven from year to year, with a variability measure of 32%.

Westlake Chemical Partners LP is priced at $20.72, above our fair value estimate of $14.75 and its safe value of $8.85.

Westlake Chemical Partners LP yields 8.99% in dividends.

Our value investing guide explains how to test these numbers against the filings themselves.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 7% below the average for stocks in the Basic Materials sector.

Its trailing P/E ratio is in line with the average for stocks in the Chemicals industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Chemicals industry, the ones closest in market capitalization to Westlake Chemical Partners LP, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
Westlake Chemical Partners LP (WLKP) 730 12.3 9.0% - 40% above
Luxfer Holdings PLC (LXFR) 464 51.0 3.0% - 105% above
Minerals Technologies (MTX) 1,801 - 0.8% 15.7% 73% below
Sensient Technologies Corporation (SXT) 4,846 28.7 1.4% 2.0% 91% above
Celanese Corporation (CE) 4,940 18.2 0.3% 14.3% 69% below
NewMarket Corporation (NEU) 6,415 14.1 1.7% 2.9% 4% above
LyondellBasell Industries N.V. (LYB) 18,050 13.5 5.9% 30.3% 88% below

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1604665.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: WLKP annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in WLKP

Does Westlake Chemical Partners LP have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: WLKP

This example shows how we apply the Trendshare checklist to WLKP: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 20.72
    • Market cap: $730M
    • EPS: 1.68
  2. Step 2 — Valuation checks

    • P/E: 12.333
    • FCF yield: —
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.